June 3 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX)
VRX.TO :
* Valeant Pharmaceuticals receives additional notice of
default under indentures due to delayed form 10-Q filing
* Company continues to expect to file form 10-Q on or before
June 10, 2016
* Notice of default does not result in acceleration of any
indebtedness of Valeant or any of its subsidiaries
* Under its senior note indentures, co has 60 days from
receipt of notice to file 10-Q, which will cure default under
related indenture
* Notice does not accelerate any of Valeant's indebtedness
Source text for Eikon: ID:nCNWQ42Fya
Further company coverage: VRX.TO
(Bengaluru Newsroom: +1-646-223-8780)